Pacheco Luis D, Saade George R, Hankins Gary D V
*Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine †Department of Anesthesiology, Division of Surgical Critical Care, The University of Texas Medical Branch at Galveston, Galveston, Texas.
Clin Obstet Gynecol. 2014 Dec;57(4):835-43. doi: 10.1097/GRF.0000000000000065.
Myocardial infarction complicating pregnancy is an important cause of maternal morbidity and mortality. The coexistence of obesity, diabetes, chronic hypertension, and delayed age at pregnancy is expected to increase the prevalence of myocardial infarction during pregnancy. Timely treatment in the form of percutaneous coronary intervention has dramatically improved outcomes. Early medical treatment with antiplatelet and antithrombotic agents is important, and maternal fetal medicine specialists must be familiar with it. In this article we will describe the basic initial medical management of patients with an acute coronary syndrome.
心肌梗死合并妊娠是孕产妇发病和死亡的重要原因。肥胖、糖尿病、慢性高血压以及妊娠年龄推迟并存，预计会增加孕期心肌梗死的患病率。经皮冠状动脉介入治疗这种及时的治疗方式显著改善了治疗效果。早期使用抗血小板和抗血栓药物进行药物治疗很重要，母胎医学专家必须熟悉这一点。在本文中，我们将描述急性冠状动脉综合征患者的基本初始药物治疗。
